Navigation Links
InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
Date:12/22/2008

International supplier of animal free, productivity enhancing cell culture media components offers its customers the chance to improve performance of cell culture development and bioproduction.

Fort Collins, CO (PRWEB) December 18, 2008 -- The 2008 Cell Engineering Conference, hosted by the Williamsburg BioProcessing Foundation, featured the products and supporting research data of InVitria, a company committed to delivering affordable, high-performing cell culture media components for bioproduction and regenerative medicine applications.

Over the course of the three day conference in Santa Barbara, CA, InVitria exhibited its Cellastim and Lacromin cell culture media component products to industry leaders seeking ways to improve their development timelines and optimize bioproduction.

InVitria's Director of Cell Culture, Dr. Steve Pettit, presented at the meeting and revealed data from a study entitled, "Recombinant Human Serum Albumin Expressed in Plants Improves the Productivity and Growth Kinetics of CHO." Tests have shown that Cellastim outperforms plasma-derived human serum albumin and can result in improved doubling time and an average 50% increase in productivity across a variety of chemically defined cell culture media.

"WilBio's Cell Engineering Conference was a great venue for InVitria to learn about the cell line development challenges facing the biopharmaceutical industry," said InVitria President Scott Deeter. "InVitria is dedicated to working with customers to improve cell line development speed by improving doubling time and expediting the development process without the use of serum or other animal components," Deeter said.

About InVitria
InVitria's Cellastim and Lacromin are animal free components used to enhance cell growth, reduce doubling times and optimize productivity in cell culture media. Cellastim and Lacromin are well-defined media components that improve performance for research, development and bioproduction.

For more information about InVitria's products, please contact us by e-mail or phone.

Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/WILBIO/INVITRIA/prweb1771634.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
2. Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
3. New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
4. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
5. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
6. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
7. KGI Offers Mammalian Cell Culture Program for Biotech Industry Professionals
8. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
9. LGE Execs Teams with Texas Tech to License Advancements in Agriculture, Health and Life Sciences
10. Improved culture system for hepatitis C virus infection
11. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... CAMBRIDGE, Mass. , Jan. 21, 2017   ... of novel compounds designed to target cancer stemness pathways, ... lead investigational compound, napabucasin, at the 2017 American Society ... San Francisco . In ... administered investigational agent designed to inhibit cancer stemness pathways ...
(Date:1/20/2017)... , Jan. 20, 2017 Ginkgo ... of Gen9, a pioneer in the synthesis and ... unique expertise in assembling pathway-length synthetic DNA into ... and capacity in the construction of new organism ... industries. "Gen9 was founded to significantly ...
(Date:1/19/2017)... 2017 Research and Markets has announced the ... Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... market is projected to reach $15,737 million by 2022 from $6,521 ... 2022. Omic technologies segment accounted for more than ...
Breaking Biology Technology:
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/8/2016)... 8, 2016  Singulex, Inc., the leader in Next ... into a license and supply agreement with Thermo Fisher ... provides Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), ... is used to diagnose systemic bacterial infection and sepsis ... to aid in assessing the risk of critically ill ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , ... expansion of its patent portfolio, which grew to over 40 granted and ... , , ... recently filed patent entitled " System, Device, and Method Estimating ... that enables device makers to forego costly hardware components needed to estimate ...
Breaking Biology News(10 mins):